University of Kansas Center for Research, Inc.


Date of Award

08.10.2022

Program

Type 1 Diabetes, Prevent & Delay

Amount

$3,025,839

Term of Grant

36 months

Project Title

Preclinical Development to advance a type 1 diabetes antigen-specific immunotherapy called SAgA-T1D